Loading

JSM Gastroenterology and Hepatology

VDR Gene SNPs in Gastrointestinal Tumors

Review Article | Open Access

  • 0. These authors have similar contributions
  • 1. Department of Clinical Medicine, Batumi Shota Rustaveli State University, Georgia
+ Show More - Show Less
Corresponding Authors
Irina Nakashidze, Department of Clinical Medicine, Batumi Shota Rustaveli State University, Batumi, 6010, Georgia; Tel: 599 593 72 36 77
Abstract

GI tumors until now remain the major health problem in the world. The numerous risk factors are related to the development of GI tumors. Vitamin D is a multifunctional hormone with functions including immunomodulation or antioxidants to several intracellular like gene regulation, signal transduction, proliferation, and invasion of cancer cells. Among the risk factors, the genetic risk factor plays an important role in susceptibility to GI tumors. However, the association between genetic variants and GI tumors remains unclear. In particular, revealing the suitable genetic biomarkers for GI may provide a new opportunity to diagnose mentioned tumors. Specifically, To determine cancer susceptibility via single-nucleotide polymorphism (SNPs). This article reviews the association of gastrointestinal tumors (esophageal, gastric, colon, liver, gallbladder, and pancreatic tumors) with VDR single nucleotide polymorphisms.

Keywords

VDR, SNP, Gastrointestinal tumors

Citation

Shaikh AP, Shaikh NP, Irina N (2022) VDR Gene SNPs in Gastrointestinal Tumors. JSM Gastroenterol Hepatol 9(2): 1111.

INTRODUCTION

Vitamin D is classically known for calcium and phosphate regulation for the mineralization of the skeletal system. However, vitamin D is a multifunctional hormone from functions including immunomodulation or antioxidants to several intracellular like gene regulation, signal transduction, proliferation, and invasion of cancer cells [1]. Studies have shown that the active form of Vitamin D, 1,25-dihydroxy vitamin D3 (VD3) is associated with inducing differentiation and cell cycle arrest in many malignant cancers such as breast, prostate, colon, skin, brain, and even in myeloid leukemia [2]. VD3 has also been shown to reduce proinflammatory stresses and function as an antiproliferative [3]. The Vitamin D receptor (VDR) gene is located on Chromosome 12q13.1. Vitamin D binds to VDR and retinoid X receptor (RXR) to form a complex that translocates to the cell nucleus and binds to the Vitamin D Response Element (VDRE), and regulates various transcriptions of genes [4]. Common VDR gene polymorphisms are FokI (exon 2, rs2228570), TaqI (exon 9, rs731236), BsmI (intron 8, rs1544410), and ApaI (intron 8, rs7975232).In this article, we review the association of various Gastrointestinal cancers, such as esophageal, gastric, colon, liver, gallbladder, and pancreatic, with VDR polymorphisms in various genetic and environmental backgrounds and ethnicities.

Vitamin D Receptor (VDR) is often considered a protective factor that prevents the development of tumors in the body. This hypothesis can mainly be explained due to the three significant effects of the VDR gene. First, when two novel epilogues were utilized to inhibit to cancer cells’ growth in vitro and in vivo, it was found that these epilogues increased the activity of Cycledependent kinase inhibitors (CKI) which in turn stop the proliferation of the cell cycle at G0 and G1 stage [5]. Furthermore, the EB1089 analog of VD reduced the multiplication and increased the levels of damage to the mitochondria and apoptosis via increased expression of Bax and decreased levels of Bcl-2 and Bcl-Xl gene in gastric cancer cells via the mitochondrialdependent apoptotic pathway [6]. Similarly, 1,25(OH)2- dihydroxy vitamin D3 (1,25(OH)2D3) inhibits cyclin D1, which is controlled via β-catenin, thus preventing the hyperproliferation of the epidermal cells on exposure to Ultraviolet radiation [7]. All in all, we can conclude that any changes/polymorphisms in the VDR gene, primarily related to the function or expression of the gene, could play a very significant role in the development of any gastrointestinal malignancy. Therefore, detecting these Single Nucleotide Polymorphisms (SNPs) needs to be extensively studied to identify the pathogenesis, prognosis, and therapeutic management of patients diagnosed with cancers due to VDR gene polymorphisms.

VDR gene SNPs in Gastric Cancer

Gastric cancer (GC) is the third leading cause of cancer deaths worldwide due to delayed diagnosis, usually during terminal stages. It is one of the most aggressive cancer with a poor prognosis and low survival [8]. Hence investigating factors influencing the development of gastric cancer is essential to reduce mortality and improve prognosis. Vitamin D demonstrates as an independent prognostic factor of gastric cancers. This is shown in studies performed on 197 gastric patients, 57.9% were deficient in Vitamin D levels, 34% were insufficient, and 8.1% were sufficient. Patients with high levels of Vitamin D demonstrated a higher survival rate compared to patients with lower levels (P=0.018). Studies showed that high Vitamin D levels were statistically significant associated with a lower risk of esophageal cancer and stomach cancer. This study’s analysis also demonstrated that an increase of 25 nmol/L in predicted VD3 levels for digestive cancers was associated with a reduction in incidence and mortality of about 43% and 45%, respectively. The strongest inverse association of Vitamin D levels and the risk of cancer was for oral/ pharyngeal cancers [9].

Cong et al. demonstrated that VDR Fokl polymorphism (rs10735810) showed an increased risk of GC development in the Chinese Han Population. Alterations in Allele occur when ATG nucleotide becomes replaced with ACG in the start codon resulting in allele change from ‘f’ to ‘F’. In this study, 187 patients and 212 healthy controls were studied. The frequency of f allele was higher in patients (51.6%) compared to healthy controls (43.6%). This f allele in Fokl polymorphism is associated with an increased risk of GC development (Ff+ff), along with higher levels of C reactive protein (CRP) compared to FF genotype and highly undifferentiated GC(p<0.05), resulting in poor prognosis and high mortality due to GC [10]. Thus early detection of highrisk patients carrying an allele can help reduce mortality and improve outcomes. Surprisingly, F allele proves to be a protective allele in the development of GC. Similar results were obtained among Kurdish population from western Iran. This case-control study investigated 99 gastric cancer patients and 100 healthy controls. Results showed a positive correlation between Fokl polymorphism and the risk of GC development (p=0.021). In addition, other polymorphisms such as Taq1, ApaI, and BsmI failed to show any statistical significance in predisposing to GC compared to healthy controls [11].

In other studies, TaqI polymorphism was related to the risk of GC. Parsamanesh et al. investigated 69 GC patients and 100 healthy individuals from the south Khorasan population of Iran. Genotyping for both FokI and TaqI was performed. TC genotype of TaqI polymorphism showed statistical significance in predisposing to cancer development (P=0.002) compared to the control group. However, this population failed to show associations with FokI phenotypes [12]. Another study observed that polymorphisms in both FokI and TaqI were not associated with risk; however, independently deficient levels of VD3 (<10ng/ ml) showed a fourfold higher predisposing and development risk of GC., The frequency of t allele was increased in patients with advanced stages of GC [13].

Bsml polymorphism also showed a strong association with GC. A case-control study carried out in the Kashmiri population reported that BsmI polymorphism was higher in Preobese GC patients (P value=0.001) and in patients with no family history of any gastrointestinal malignancy (P value=0.014), concluding that Bsml polymorphism in patients with High BMI was strongly associated with increased risk however Apal and Taql were not [14].

Wen et al., reported an interesting correlation between the expression of VDR in normal, precancerous, and cancerous gastric cells. VDR expression was significantly lower in cancerous gastric cells (57.61%) (P value=0.001). Moreover, between cancerous cells, increased number of VDR was found in well-differentiated tissues compared to poorly differentiated cancerous tissue and in small-sized tumors (<5cm) (P value=0.016 and P value =0.009 respectively). Hence, the expression of VDR can serve as an essential prognostic factor for GC [15].

VDR gene SNPs in Liver cancer

Hepatocellular Carcinoma (HCC) has multifactorial risks. Viral infections such as Hepatitis B (HBV), Hepatitis C (HCV) and alcohol consumption are amongst most common worldwide. Numerous studies have reported an association of HCC and VDR polymorphism. Falleti et al., conducted research in Italian population consisting of 80 HCC patients and 236 healthy controls. Patients carrying b/b genotype of BsmI and T/T genotype of TaqI had high susceptibility of HCC (P<0.05). Moreover, patients lacking the protective allele A-T-C were significantly associated with risk of HCC. Patients with alcoholic liver disease demonstrated that the presence of BAT A-T-C and G-T-T genotypes also showed a strong correlation. Hence, HCC patients with alcoholic liver showed a specific link to HCC development [16]. However, In Vietnamese population, TaqI, FokI, and BsmI polymorphism failed to show any association or clinical presentation in HCC patients. However, the frequency of ApaI AA genotype was higher in HCC patients compared to chronic HBV infective patients (p=0.04). In contrast, ApaI CA genotype showed no significant association [17].

Fok1 polymorphism is also linked to HCC development and prognosis. Peng et al., reported that in Chinese HCC and HBV patients, VDR Fok1 polymorphism was studied. TT/CC genotypes exhibited increased HBV-related HCC developmental risk in contrast to CC genotype, while VDR rs11568820, and rs3782905 showed no such association. Interestingly, patients with Vitamin D binding protein (DBP) rs7041 GG and GG/TG genotypes had higher HCC risk chances than the TT genotype. Suggesting that Fok1 and DBP rs7041polymorphisms were associated with increased risk in HBV related HCC patients in the Chinese population [18]. Likewise, Apa1 polymorphism has been shown as a possible independent biomarker for HCV cirrhosis-related HCC development. Raafat Rowida et al., reported that SNP such as Apa1 could solve a healthcare burden of HCV-related liver cirrhosis leading to HCC by predicting diagnosis and thus initiating early management. This study done in Egyptian population included 80 HCC patients with diagnosed HCV, 80 HCV cirrhotic patients with no HCC development, and 80 healthy controls. Results were as follows, Apa1 CC genotype was highly observed in HCC patients, about 75%, compared to cirrhotic patients (35%) and controls (20%) (p<0.0001). Moreover, patients with CC genotypes had severe Child-Pugh scores(P=0.027) and Model for End-Stage Liver Disease (MELD) score (P<0.05). Suggesting a higher risk for poor prognosis in CC genotype patients [19].

VDR gene SNPs in Esophageal Cancers

VDR polymorphism variations are associate with Esophageal Adenocarcinoma (EAC) and Barrett Esophagus (BE) development. Janmaat et al. studied this relation in 858 patients with reflux esophagitis (RE), EAC, or BE and 202 healthy controls. rs1989969T/rs2238135G was associated with two-fold reduced incidence risk of RE, EAC, and BE. BE patients carrying 2 copies of rs2238135 G allele were associated with 2.5 times reduced expression of VDR compared to patients having 2 copies of rs2238135 C allele (p = 0.01). Similarly, subjects carrying 2 copies of T allele of rs1989969 showed a 2-fold reduced expression of VDR than patients carrying C allele. Consequently, establishing genetic variation with different risk frequencies. Furthermore, suggesting a potential benefit from Vitamin D chemotherapy in patients carrying higher frequency of rs1989969 T and rs2238135 G alleles [20]. On the contrary, Chang et al., reported that SNP rs2238135 showed no significant association with EAC in Ireland population-based case-control study. Chang et al., also analyzed rs2238139 (277+2550 C>T) and rs2107301 (277+3260 C>T) TT homozygotes, showing a statistically significantly lower risk for EAC development when compared to CC genotype [21].

Studies on the western population also reveal exciting outcomes. Trowbridge et al. reported that expression of VDR in the United States is significantly decreased with EAC dedifferentiation meaning low levels of VDR was observed in high-grade tumors. This could open scope for VDR expression levels as a marker for responsiveness to neoadjuvant therapy [22].

A metanalysis on VDR polymorphisms and risk of tobaccorelated cancer (Esophageal, oral, neck, lung, liver, and head cancers) suggested that increased frequency of “t” allele of Taql polymorphism reduced the occurrence of such cancers by 17% (p=0.0114, OR=0.83, 0.72-0.96 95% CI). Fokl, Bsml and Apal polymorphisms did not show any statistically significant association [23].

VDR gene SNPS in Gallbladder cancer

Gallbladder Cancer (GBC) is the most cancer of the digestive tract [24]. GBC patients are also victims of VDR polymorphisms influencing susceptibility. Li et al., conducted a study in Chinese population analyzing Fokl, ApaI, BsmI, and TaqI polymorphisms with GBC risk. 291 GBC patients and 396 age and gendermatched healthy controls were studied. Fokl TT polymorphisms were significantly increased in patients compared to controls (38.14 vs 22.73%, P < 0.001). Moreover, patients carrying higher frequency of CC and TC genotypes had greater Odds ratio (OR), suggesting that C allele is significantly associated with GBC incidence. Apal, Bsml,Taql polymorphisms did not show any statistically significant association [25].

VDR gene SNPs in Pancreatic cancer

Pancreatic cancer is one the most aggressive and invasive malignancies. It generally presents with a poor prognosis; therefore, identifying its core cause is vital for the patients. Once such risk factors for developing pancreatic cancer are gene polymorphisms, particularly the Vitamin D Receptor (VDR) gene polymorphism, these VDR gene polymorphisms could profoundly affect the course and differentiation of cancer.

A case-control study was conducted in Asia to evaluate whether VDR gene polymorphisms were associated with pancreatic cancer; two specific polymorphisms were identified, namely rs2228570 and rs1544410. Histopathological analysis of the samples was conducted in patients diagnosed with pancreatic adenocarcinoma. Genotyping of the above two mentioned genes was done, and statistical analysis was performed. It was reported that the rs2228570 gene polymorphism, the genotype TT showed a significant increased likelihood of pancreatic cancer (univariate: OR= 3.02, 95 % CI=1.92–4.76, P<0.01), and the genotype with one T gene demonstrated similar results (univariate: OR=2.42, 95 % CI=1.72–3.42, P<0.01). Furthermore, the prevalence of T allele was higher in patients with pancreatic cancer (OR=1.869, 95 % CI=1.489– 2.347, P=0.0001). As for the rs2228570 gene polymorphism, the presence of one G gene loci will decrease the risk of pancreatic cancer (univariate: OR=0.63, 95 % CI=0.45– 0.89). Overall, it was reported that the G allele could reduce the cancer risk (OR=0.76, 95 % CI=0.60–0.95, P=0.01). Thus, it was found that the rs2228570 polymorphism was related to the differentiation of cancer, and the rs1544410 polymorphism was associated with the TNM classification. These VDR gene polymorphisms are a potential risk factor for the development of pancreatic cancer. They could identify the susceptibility and prognosis for this condition and possibly guide the treatment for the patient [26].

VDR gene SNPs in Colon Cancer

VDR SNPs may have some contribution to cancers. Colon cancer (CC) is a severe global health problem, among other gastrointestinal (GI) tumors. As already confirmed, genetic risk factors have a crucial contribution to CC. It is suggested that the VDR gene SNPs [27]. The SNP of rs11064124 in 12p13.31 revealed a higher risk of colon adenocarcinoma. It was also suggested that VDR interacts with two target gene promoters, causing the coactivation of CD9 and PLEKHG6 transcription in colon adenocarcinoma. VDR SNPs have been associated increase susceptibility to colorectal cancer [28]. The study by Messaritakis et al. (2020) confirmed the vital role of VDR SNPs in carcinogenesis, disease progression, and patients’ survival in CRC. Furthermore, the same study indicated that the expressed VDR is associated with patients’ survival [29].

The genetic variation at the VDR, particularly the FokI SNPs, is associated with CC risk [30]. Thus, studies suggest that VDR gene SNPs may significantly play a key role in GI cancer’s predisposition and development [31-36].

CONCLUSION

Thus, Based on the existing research, there is an association between VDR gene SNPs and GI tumors. We have thought that revealing associated VDR SNPs for GI tumors may use as a new opportunity in diagnosis and therapy.

REFERENCES

1. Feldman D, Krishnan AV, Swami S, Giovannucci E, Feldman BJ. The role of vitamin D in reducing cancer risk and progression. Nat Rev Cancer. 2014; 14: 342-357.

2. Holick MF. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr. 2004; 80: 1678S-1688S.

3. Fleet JC. Molecular actions of vitamin D contributing to cancer prevention. Mol Aspects Med. 2008; 29: 388-396.

4. Haussler MR, Jurutka PW, Mizwicki M, Norman AW. Vitamin D receptor (VDR)-mediated actions of 1α, 25 (OH) 2vitamin D3: genomic and non-genomic mechanisms. Best Pract Res Clin Endocrinol Metab. 2011; 25: 543-559.

5. Verlinden L, Verstuyf A, Van Camp M, Marcelis S, Sabbe K, Zhao XY, et al. Two novel 14-Epi-analogues of 1, 25-dihydroxyvitamin D3 inhibit the growth of human breast cancer cells in vitro and in vivo. Cancer Res. 2000; 60: 2673-2679.

6. Wang W, Zhao CH, Zhang N, Wang J. Vitamin D analog EB1089 induces apoptosis in a subpopulation of SGC-7901 gastric cancer cells through a mitochondrial-dependent apoptotic pathway. Nutr Cancer. 2013; 65: 1067-1075.

7. Jiang YJ, Teichert AE, Fong F, Oda Y, Bikle DD. 1α, 25 (OH) 2-dihydroxyvitamin D3/VDR protects the skin from UVB-induced tumor formation by interacting with the β-catenin pathway. J Steroid Biochem Mol Biol. 2013; 136: 229-232.

8. Guggenheim DE, Shah MA. Gastric cancer epidemiology and risk factors. J Surg Oncol. 2013; 107: 230-236.

9. Giovannucci E, Liu Y, Rimm EB, Hollis BW, Fuchs CS, Stampfer MJ, et al. Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst. 2006; 98: 451-459.

10.Cong L, Wang WB, Liu Q, Du JJ. FokI Polymorphism of the vitamin D receptor gene is associated with susceptibility to gastric cancer: A case-control study. Tohoku J Exp Med. 2015; 236: 219-224.

11. Hoseinkhani Z, Rastegari-Pouyani M, Tajemiri F, Yari K, Mansouri K. Association of vitamin D receptor polymorphisms (FokI (Rs2228570), ApaI (Rs7975232), BsmI (Rs1544410), and TaqI (Rs731236)) with gastric cancer in a Kurdish population from west of Iran. Rep Biochem Mol Biol. 2021; 9: 435.

12. Parsamanesh N, Moossavi M, Tavakkoli T, Javdani H, Fakharian T, Moossavi SZ, et al. Positive correlation between vitamin D receptor gene TaqI variant and gastric cancer predisposition in a sample of Iranian population. J Cell Physiol. 2019; 234: 15044-15047.

13. Durak ?, Gheybi A, Demirkol ?, Ar?kan S, Zeybek ?Ü, Akyüz F, et al. The effects of serum levels, and alterations in the genes of binding protein and receptor of vitamin D on gastric cancer. Mol Biol Rep. 2019; 46: 6413-6420.

14.Qadir J, Majid S, Khan MS, Wani MD. Association of Vitamin D receptor gene variations with Gastric cancer risk in Kashmiri population. Mol Biol Rep. 2021; 48: 3313-3325.

15. Wen Y, Da M, Zhang Y, Peng L, Yao J, Duan Y. Alterations in vitamin D signaling pathway in gastric cancer progression: a study of vitamin D receptor expression in human normal, premalignant, and malignant gastric tissue. Int J Clin Exp Pathol. 2015; 8: 13176.

16. Falleti E, Bitetto D, Fabris C, Cussigh A, Fontanini E, Fornasiere E, et al. Vitamin D receptor gene polymorphisms and hepatocellular carcinoma in alcoholic cirrhosis. World J Gastroenterol. 2010; 16: 3016.

17. Hoan NX, Khuyen N, Giang DP, Binh MT, Toan NL, Anh DT, et al. Vitamin D receptor ApaI polymorphism associated with progression of liver disease in Vietnamese patients chronically infected with hepatitis B virus. BMC Med Genet. 2019; 20: 1-12.

18. Peng Q, Yang S, Lao X, Li R, Chen Z, Wang J. Association of single nucleotide polymorphisms in VDR and DBP genes with HBV-related hepatocellular carcinoma risk in a Chinese population. PloS one. 2014; 9: e116026.

19. Raafat Rowida I, Eshra KA, El-Sharaby RM, Eissa RAE, Saied SM, Amer I, et al. Apa1 (rs7975232) SNP in the vitamin D receptor is linked to hepatocellular carcinoma in hepatitis C virus cirrhosis. Br J Biomed Sci. 2020; 77: 53-57.

20. Janmaat VT, Van De Winkel A, Peppelenbosch MP, Spaander MC, Uitterlinden AG, Pourfarzad F, et al. Vitamin D receptor polymorphisms are associated with reduced esophageal vitamin D receptor expression and reduced esophageal adenocarcinoma risk. Mol Med. 2015; 21: 346-354.

21. Chang CK, Mulholland HG, Cantwell MM, Anderson LA, Johnston BT, McKnight AJ, et al. Vitamin D receptor gene variants and esophageal adenocarcinoma risk: a population-based case–control study. J Gastrointest Cancer. 2012; 43: 512-517.

22.Trowbridge R, Sharma P, Hunter WJ, Agrawal DK. Vitamin D receptor expression and neoadjuvant therapy in esophageal adenocarcinoma. Exp Mol Pathol. 2012; 93: 147-153.

23. Laczmanski L, Laczmanska I, Lwow F. Association of select vitamin D receptor gene polymorphisms with the risk of tobacco-related cancers–a meta-analysis. Sci Rep. 2019; 9: 1-7.

24. Erickson BA, Nag S. Biliary tree malignancies. J Surg Oncol. 1998; 67: 203-210.

25. Li Z, Yuan WT, Ning SJ, Zhang SJ. Vitamin D receptor genetic variants are associated with susceptibility of gallbladder adenocarcinoma in a Chinese cohort. Genet Mol Res. 2014; 13: 5387-5394.

26. Li L, Shang F, Zhang W, Zhang C, Li J, Wang C, et al. Role of vitamin D receptor gene polymorphisms in pancreatic cancer: a case–control study in China. Tumor Biol. 2015; 36: 4707-4714.

27. Nakashidze I, Petrovi? N, Kedelidze N, Dariya B. Clinical Significance of Genetic Variants in Colon Cancer. Colon Cancer Diagnosis and Therapy. 2022; 3: 69-91.

28.Touvier M, Chan DS, Lau R, Aune D, Vieira R, Greenwood DC, et al. Meta-Analyses of Vitamin D Intake, 25-Hydroxyvitamin D Status, Vitamin D Receptor Polymorphisms, and Colorectal Cancer Risk. Cancer Epidemiol Biomarkers Prev. 2011; 20: 1003-1016.

29. Messaritakis I, Koulouridi A, Sfakianaki M, Vogiatzoglou K, Gouvas N, Athanasakis E, et al. The role of vitamin D receptor gene polymorphisms in colorectal cancer risk. Cancers. 2020; 12: 1379.

30. Ochs-Balcom HM, Cicek MS, Thompson CL, Tucker TC, Elston RC, JPlummer S, et al. Association of vitamin D receptor gene variants, adiposity and colon cancer. Carcinogenesis. 2008; 29: 1788-1793.

31. Alkhayal KA, Awadalia ZH, Vaali-Mohammed MA, Al Obeed OA, Al Wesaimer A, Halwani R, et al. Association of vitamin D receptor gene polymorphisms with colorectal cancer in a Saudi Arabian population. PLoS One. 2016; 11: e0155236.

32. Messaritakis I, Koulouridi A, Sfakianaki M, Vogiatzoglou K, Gouvas N, Athanasakis E, et al. The role of vitamin D receptor gene polymorphisms in colorectal cancer risk. Cancers. 2020; 12: 1379.

33. De Mattia E, Polesel J, Roncato R, Labriet A, Bignucolo A, Dreussi E, et al. Germline polymorphisms in the nuclear receptors PXR and VDR as novel prognostic markers in metastatic colorectal cancer patients treated with FOLFIRI. Front Oncol. 2019; 9: 1312.

34. Serrano D, Gnagnarella P, Raimondi S, Gandini S. Meta-analysis on vitamin D receptor and cancer risk: focus on the role of TaqI, ApaI, and Cdx2 polymorphisms. Eur J Cancer Prev. 2016; 25: 85.

35. Gu H, Wang X, Zheng L, Tang W, Dong C, Wang L, et al. Vitamin D receptor gene polymorphisms and esophageal cancer risk in a Chinese population: a negative study. Med Oncol. 2014; 31: 1-7.

36. Chen LW, Chang LC, Hua CC, Cheng TC, Lee CC. Comparing the expressions of Vitamin D receptor, cell proliferation, and apoptosis in gastric mucosa with gastritis, intestinal metaplasia, or adenocarcinoma change. Front Med (Lausanne). 2021; 8: 766061.

Shaikh AP, Shaikh NP, Irina N (2022) VDR Gene SNPs in Gastrointestinal Tumors. JSM Gastroenterol Hepatol 9(2): 1111.

Received : 08 Dec 2022
Accepted : 14 Dec 2022
Published : 16 Dec 2022
Journals
Annals of Otolaryngology and Rhinology
ISSN : 2379-948X
Launched : 2014
JSM Schizophrenia
Launched : 2016
Journal of Nausea
Launched : 2020
JSM Internal Medicine
Launched : 2016
JSM Hepatitis
Launched : 2016
JSM Oro Facial Surgeries
ISSN : 2578-3211
Launched : 2016
Journal of Human Nutrition and Food Science
ISSN : 2333-6706
Launched : 2013
JSM Regenerative Medicine and Bioengineering
ISSN : 2379-0490
Launched : 2013
JSM Spine
ISSN : 2578-3181
Launched : 2016
Archives of Palliative Care
ISSN : 2573-1165
Launched : 2016
JSM Nutritional Disorders
ISSN : 2578-3203
Launched : 2017
Annals of Neurodegenerative Disorders
ISSN : 2476-2032
Launched : 2016
Journal of Fever
ISSN : 2641-7782
Launched : 2017
JSM Bone Marrow Research
ISSN : 2578-3351
Launched : 2016
JSM Mathematics and Statistics
ISSN : 2578-3173
Launched : 2014
Journal of Autoimmunity and Research
ISSN : 2573-1173
Launched : 2014
JSM Arthritis
ISSN : 2475-9155
Launched : 2016
JSM Head and Neck Cancer-Cases and Reviews
ISSN : 2573-1610
Launched : 2016
JSM General Surgery Cases and Images
ISSN : 2573-1564
Launched : 2016
JSM Anatomy and Physiology
ISSN : 2573-1262
Launched : 2016
JSM Dental Surgery
ISSN : 2573-1548
Launched : 2016
Annals of Emergency Surgery
ISSN : 2573-1017
Launched : 2016
Annals of Mens Health and Wellness
ISSN : 2641-7707
Launched : 2017
Journal of Preventive Medicine and Health Care
ISSN : 2576-0084
Launched : 2018
Journal of Chronic Diseases and Management
ISSN : 2573-1300
Launched : 2016
Annals of Vaccines and Immunization
ISSN : 2378-9379
Launched : 2014
JSM Heart Surgery Cases and Images
ISSN : 2578-3157
Launched : 2016
Annals of Reproductive Medicine and Treatment
ISSN : 2573-1092
Launched : 2016
JSM Brain Science
ISSN : 2573-1289
Launched : 2016
JSM Biomarkers
ISSN : 2578-3815
Launched : 2014
JSM Biology
ISSN : 2475-9392
Launched : 2016
Archives of Stem Cell and Research
ISSN : 2578-3580
Launched : 2014
Annals of Clinical and Medical Microbiology
ISSN : 2578-3629
Launched : 2014
JSM Pediatric Surgery
ISSN : 2578-3149
Launched : 2017
Journal of Memory Disorder and Rehabilitation
ISSN : 2578-319X
Launched : 2016
JSM Tropical Medicine and Research
ISSN : 2578-3165
Launched : 2016
JSM Head and Face Medicine
ISSN : 2578-3793
Launched : 2016
JSM Cardiothoracic Surgery
ISSN : 2573-1297
Launched : 2016
JSM Bone and Joint Diseases
ISSN : 2578-3351
Launched : 2017
JSM Bioavailability and Bioequivalence
ISSN : 2641-7812
Launched : 2017
JSM Atherosclerosis
ISSN : 2573-1270
Launched : 2016
Journal of Genitourinary Disorders
ISSN : 2641-7790
Launched : 2017
Journal of Fractures and Sprains
ISSN : 2578-3831
Launched : 2016
Journal of Autism and Epilepsy
ISSN : 2641-7774
Launched : 2016
Annals of Marine Biology and Research
ISSN : 2573-105X
Launched : 2014
JSM Health Education & Primary Health Care
ISSN : 2578-3777
Launched : 2016
JSM Communication Disorders
ISSN : 2578-3807
Launched : 2016
Annals of Musculoskeletal Disorders
ISSN : 2578-3599
Launched : 2016
Annals of Virology and Research
ISSN : 2573-1122
Launched : 2014
JSM Renal Medicine
ISSN : 2573-1637
Launched : 2016
Journal of Muscle Health
ISSN : 2578-3823
Launched : 2016
JSM Genetics and Genomics
ISSN : 2334-1823
Launched : 2013
JSM Anxiety and Depression
ISSN : 2475-9139
Launched : 2016
Clinical Journal of Heart Diseases
ISSN : 2641-7766
Launched : 2016
Annals of Medicinal Chemistry and Research
ISSN : 2378-9336
Launched : 2014
JSM Pain and Management
ISSN : 2578-3378
Launched : 2016
JSM Women's Health
ISSN : 2578-3696
Launched : 2016
Clinical Research in HIV or AIDS
ISSN : 2374-0094
Launched : 2013
Journal of Endocrinology, Diabetes and Obesity
ISSN : 2333-6692
Launched : 2013
Journal of Substance Abuse and Alcoholism
ISSN : 2373-9363
Launched : 2013
JSM Neurosurgery and Spine
ISSN : 2373-9479
Launched : 2013
Journal of Liver and Clinical Research
ISSN : 2379-0830
Launched : 2014
Journal of Drug Design and Research
ISSN : 2379-089X
Launched : 2014
JSM Clinical Oncology and Research
ISSN : 2373-938X
Launched : 2013
JSM Bioinformatics, Genomics and Proteomics
ISSN : 2576-1102
Launched : 2014
JSM Chemistry
ISSN : 2334-1831
Launched : 2013
Journal of Trauma and Care
ISSN : 2573-1246
Launched : 2014
JSM Surgical Oncology and Research
ISSN : 2578-3688
Launched : 2016
Annals of Food Processing and Preservation
ISSN : 2573-1033
Launched : 2016
Journal of Radiology and Radiation Therapy
ISSN : 2333-7095
Launched : 2013
JSM Physical Medicine and Rehabilitation
ISSN : 2578-3572
Launched : 2016
Annals of Clinical Pathology
ISSN : 2373-9282
Launched : 2013
Annals of Cardiovascular Diseases
ISSN : 2641-7731
Launched : 2016
Journal of Behavior
ISSN : 2576-0076
Launched : 2016
Annals of Clinical and Experimental Metabolism
ISSN : 2572-2492
Launched : 2016
Clinical Research in Infectious Diseases
ISSN : 2379-0636
Launched : 2013
JSM Microbiology
ISSN : 2333-6455
Launched : 2013
Journal of Urology and Research
ISSN : 2379-951X
Launched : 2014
Journal of Family Medicine and Community Health
ISSN : 2379-0547
Launched : 2013
Annals of Pregnancy and Care
ISSN : 2578-336X
Launched : 2017
JSM Cell and Developmental Biology
ISSN : 2379-061X
Launched : 2013
Annals of Aquaculture and Research
ISSN : 2379-0881
Launched : 2014
Clinical Research in Pulmonology
ISSN : 2333-6625
Launched : 2013
Journal of Immunology and Clinical Research
ISSN : 2333-6714
Launched : 2013
Annals of Forensic Research and Analysis
ISSN : 2378-9476
Launched : 2014
JSM Biochemistry and Molecular Biology
ISSN : 2333-7109
Launched : 2013
Annals of Breast Cancer Research
ISSN : 2641-7685
Launched : 2016
Annals of Gerontology and Geriatric Research
ISSN : 2378-9409
Launched : 2014
Journal of Sleep Medicine and Disorders
ISSN : 2379-0822
Launched : 2014
JSM Burns and Trauma
ISSN : 2475-9406
Launched : 2016
Chemical Engineering and Process Techniques
ISSN : 2333-6633
Launched : 2013
Annals of Clinical Cytology and Pathology
ISSN : 2475-9430
Launched : 2014
JSM Allergy and Asthma
ISSN : 2573-1254
Launched : 2016
Journal of Neurological Disorders and Stroke
ISSN : 2334-2307
Launched : 2013
Annals of Sports Medicine and Research
ISSN : 2379-0571
Launched : 2014
JSM Sexual Medicine
ISSN : 2578-3718
Launched : 2016
Annals of Vascular Medicine and Research
ISSN : 2378-9344
Launched : 2014
JSM Biotechnology and Biomedical Engineering
ISSN : 2333-7117
Launched : 2013
Journal of Hematology and Transfusion
ISSN : 2333-6684
Launched : 2013
JSM Environmental Science and Ecology
ISSN : 2333-7141
Launched : 2013
Journal of Cardiology and Clinical Research
ISSN : 2333-6676
Launched : 2013
JSM Nanotechnology and Nanomedicine
ISSN : 2334-1815
Launched : 2013
Journal of Ear, Nose and Throat Disorders
ISSN : 2475-9473
Launched : 2016
JSM Ophthalmology
ISSN : 2333-6447
Launched : 2013
Journal of Pharmacology and Clinical Toxicology
ISSN : 2333-7079
Launched : 2013
Annals of Psychiatry and Mental Health
ISSN : 2374-0124
Launched : 2013
Medical Journal of Obstetrics and Gynecology
ISSN : 2333-6439
Launched : 2013
Annals of Pediatrics and Child Health
ISSN : 2373-9312
Launched : 2013
JSM Clinical Pharmaceutics
ISSN : 2379-9498
Launched : 2014
JSM Foot and Ankle
ISSN : 2475-9112
Launched : 2016
JSM Alzheimer's Disease and Related Dementia
ISSN : 2378-9565
Launched : 2014
Journal of Addiction Medicine and Therapy
ISSN : 2333-665X
Launched : 2013
Journal of Veterinary Medicine and Research
ISSN : 2378-931X
Launched : 2013
Annals of Public Health and Research
ISSN : 2378-9328
Launched : 2014
Annals of Orthopedics and Rheumatology
ISSN : 2373-9290
Launched : 2013
Journal of Clinical Nephrology and Research
ISSN : 2379-0652
Launched : 2014
Annals of Community Medicine and Practice
ISSN : 2475-9465
Launched : 2014
Annals of Biometrics and Biostatistics
ISSN : 2374-0116
Launched : 2013
JSM Clinical Case Reports
ISSN : 2373-9819
Launched : 2013
Journal of Cancer Biology and Research
ISSN : 2373-9436
Launched : 2013
Journal of Surgery and Transplantation Science
ISSN : 2379-0911
Launched : 2013
Journal of Dermatology and Clinical Research
ISSN : 2373-9371
Launched : 2013
TEST Journal of Dentistry
ISSN : 1234-5678
Launched : 2014
Annals of Nursing and Practice
ISSN : 2379-9501
Launched : 2014
JSM Dentistry
ISSN : 2333-7133
Launched : 2013
Author Information X